Founded in 2020 under the dynamic and visionary leadership of Mr. Rakesh Sutariya, Zenovel has embarked on a remarkable journey to simplify regulatory complexities while upholding the highest standards of ethical integrity.
In just four years, we have established ourselves as a trusted partner in the healthcare and pharmaceutical sectors, setting new benchmarks of excellence through innovation and unwavering commitment. Our team, a powerhouse of expertise, combines over a decade of collective experience. This unique blend of industry veterans and forward-thinking professionals enables us to anticipate and adapt to emerging trends, helping our clients maintain a competitive edge.
Zenovel’s dedication to excellence and client success has fuelled our expansion across multiple nations, strengthening our global footprint. Our GMP support services, lauded by clients worldwide, exemplify our unwavering commitment to quality and reliability.
With an impressive track record of 332 successful audits for prominent companies, we have consistently nurtured partnerships, built trust, and catalysed transformative growth for our clients. This dedication earned us the prestigious recognition as one ofIndia Pharma Outlook’s Top 10 Pharmaceutical Regulatory Consultants for 2024. This accolade underscores our leadership in the field and reinforces our position as the preferred partner for pharmaceutical and healthcare organizations globally.
At Zenovel, we take pride in our customer-centric approach. We have supported over 50 international clients in achieving their healthcare goals, offering tailored solutions to navigate regulatory landscapes, ensure compliance, and drive innovation.
As we expand our horizons, Zenovel remains steadfast in its commitment to fostering partnerships built on integrity, transparency, and quality. Together, we are shaping the future of pharmaceutical quality control and healthcare—one milestone at a time.
After reaching significant milestones in our journey so far, Zenovel looks forward to an even brighter and more impactful future. Our strategy is rooted in the belief that success is achieved in stages, with each action taken today laying the foundation for future accomplishments.
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is the
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
Navigating the world of pharmaceuticals, medical devices, and biotechnology is never straightforward. With the diversity of regulatory compliance governs the Code of Federal Regulations (CFR) – a regulatory path that shapes companies’ efforts and implements how companies long for their products to be developed, manufactured, and marketed. For companies trying
The race to deliver life-saving therapies to patients is increasingly faster and more complex. Pharmaceutical and biotech companies are faced with a dizzying list of challenges — global clinical trials, continuously changing regulations, multiple complicated therapeutic areas, and pressure to innovate. This is where Contract Research Organizations (CRO) come in:
